JNJ - Johnson & Johnson inks licensing deal with Quanterix for Alzheimer's testing
2023-10-24 06:43:50 ET
More on Quanterix
- Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology
- Quanterix Corporation (QTRX) Q2 2023 Earnings Call Transcript
- Quanterix Corporation 2023 Q2 - Results - Earnings Call Presentation
- Quanterix upgraded to buy at Canaccord on assay redevelopment program
- Seeking Alpha’s Quant Rating on Quanterix
For further details see:
Johnson & Johnson inks licensing deal with Quanterix for Alzheimer's testing